|
Ed brings over 12 years of combined biopharmaceutical industry and financial management experience. From 2000 to 2005, he was Executive Director of Finance at InKine Pharmaceutical Company, Inc. (ultimately acquired by Salix Pharmaceuticals, Ltd.). Ed started his career in public accounting where he held positions of increasing responsibility, most recently at Deloitte & Touche LLP. Ed is licensed as a Certified Public Accountant in Pennsylvania and holds a B.S. degree in Business Administration from the University of Hartford.
| 